Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Nelson

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Prostate|September 10, 2008
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancerJohn K Scariano, Eric Treat, Frances Alba, et al.
Pharmacoeconomics|August 6, 2004
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthmaRichard D O'Connor, Harold Nelson, Rohit Borker, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthmaMarc Massanari, Harold Nelson, Thomas Casale, et al.
Clinical Therapeutics|September 1, 2004
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance dataWilliam DuMouchel, Eric T Smith, Richard Beasley, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trialsHarold Nelson, Catherine Bonuccelli, Finn Radner, et al.
Frontiers in Microbiology|June 9, 2025
Avocado rhizosphere community profiling: white root rot and its impact on microbial compositionPhinda Magagula, Velushka Swart, Arista Fourie, et al.
COPD|March 11, 2010
The safety and efficacy of arformoterol and formoterol in COPDNicola A Hanania, James F Donohue, Harold Nelson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2007
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled studyHarold Nelson, James Kemp, William Berger, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2013
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus reportA Wesley Burks, Moises A Calderon, Thomas Casale, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Prostate|September 10, 2008
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancerJohn K Scariano, Eric Treat, Frances Alba, et al.
Pharmacoeconomics|August 6, 2004
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthmaRichard D O'Connor, Harold Nelson, Rohit Borker, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthmaMarc Massanari, Harold Nelson, Thomas Casale, et al.
Clinical Therapeutics|September 1, 2004
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance dataWilliam DuMouchel, Eric T Smith, Richard Beasley, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trialsHarold Nelson, Catherine Bonuccelli, Finn Radner, et al.
Frontiers in Microbiology|June 9, 2025
Avocado rhizosphere community profiling: white root rot and its impact on microbial compositionPhinda Magagula, Velushka Swart, Arista Fourie, et al.
COPD|March 11, 2010
The safety and efficacy of arformoterol and formoterol in COPDNicola A Hanania, James F Donohue, Harold Nelson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2007
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled studyHarold Nelson, James Kemp, William Berger, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2013
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus reportA Wesley Burks, Moises A Calderon, Thomas Casale, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Pageof 3